Moncef Slaoui departs Galvani Bioelectronics board of directors
The board of directors of GlaxoSmithKline, the majority shareholder of Galvani Bioelectronics, has announced the termination of Moncef Slaoui as chair of the Galvani board...
Wed, 24/03/2021 - 14:31